Financials

  • Market Capitalization 362.19 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2
市销率
11.96

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3163
FENC
Fennec Pharmaceuticals Inc. - Common Stock
10.62 USD-4.84%+3.71%+14.07%+20.27%368.91 M USD
3165
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.69 USD+1.52%-7.31%-0.64%+12.74%368.27 M USD
3188
PRLD
Prelude Therapeutics Incorporated - Common Stock
4.50 USD+2.51%-10.89%+2.97%+455.56%358.40 M USD
3199
PALI
Palisade Bio, Inc. - Common Stock
2.04 USD+5.70%+3.03%+21.43%+20.00%354.10 M USD

新闻